John Weinerth, MD, professor emeritus of surgery, died on September 2, 2026.
It is a privilege to remember and celebrate Dr. John Weinerth, whose remarkable career and life were so closely intertwined with Duke and Duke Urology.
A graduate of Harvard Medical School, John came to Duke for his surgical and urologic training under two legendary figures in Duke medicine, Dr. David Sabiston and Dr. James Glenn. His residency was interrupted by two years of service in the United States Navy, where, remarkably, he helped develop the first tissue bank on the West Coast. He subsequently returned to Duke, completed his training, and joined the faculty in the Division of Urology under Dr. Glenn.
John's early clinical passion centered on the kidney—particularly urinary stone disease and renal transplantation. He worked closely with colleagues in General Surgery in the development and management of Duke's renal transplant program, participating both in the surgical care of patients and in the evaluation of potential transplant candidates. This was an era when transplantation was rapidly evolving, and John's contributions reflected the clinical innovation and multidisciplinary collaboration that would characterize his career.
That same spirit of innovation became particularly important as the treatment of kidney stones began to change dramatically.
With the emergence of endoscopic techniques and extracorporeal shock wave lithotripsy, urologists could increasingly treat kidney stones without the major open operations that had previously been required. John recognized the importance of these advances early. Together with his colleague Dr. Culley Carson, he helped establish and expand the Minimally Invasive Stone Management Program at Duke, bringing these emerging technologies to our patients and helping develop what would become Duke's modern endourologic practice.
For those of us practicing urology today, it can be difficult to appreciate just how transformative these developments were. John and Culley were introducing approaches that fundamentally changed how we cared for patients with stone disease. Their willingness to embrace new technologies, build the necessary clinical expertise, and incorporate these techniques into everyday practice helped establish a foundation upon which generations of Duke endourologists have continued to build.
That clinical legacy alone would represent a distinguished career. But John's other great passion—and perhaps his most far-reaching legacy—was education.
John was deeply committed to training the next generation of physicians. He served as Residency Program Director for the Division of Urology, where he helped educate and mentor a generation of Duke urologists. He understood that our responsibility as educators extends well beyond teaching someone how to perform an operation. We are entrusted with developing physicians—with teaching clinical judgment, professionalism, responsibility, curiosity, and, most importantly, how to care for patients.
His abilities as an educator and leader eventually took him far beyond Urology.
After retiring from active clinical practice, John assumed a major leadership role in graduate medical education at Duke. He served as Duke's Designated Institutional Official, with responsibility for the oversight of graduate medical education across the institution during a period of profound change in how residency and fellowship programs were structured, monitored, and accredited.
This was an enormously important responsibility. As expectations for institutional oversight, resident supervision, work hours, patient safety, and educational accountability grew, John helped Duke navigate that changing environment. He not only led that transition but also contributed to the broader academic discussion by publishing Duke's early experience with these changes in graduate medical education.
Think about the reach of that contribution. John began by teaching Duke urology residents. He ultimately became responsible for helping ensure the quality of training for residents and fellows throughout Duke. His influence therefore extended well beyond our department and our specialty to generations of physicians trained across Duke Medicine.
His contributions were appropriately recognized. In 2001, John received the Duke University Distinguished Faculty Award, and in 2007, the Accreditation Council for Graduate Medical Education honored him with the Parker J. Palmer Courage to Lead Award—a particularly fitting recognition for someone who devoted so much of his career to the education and development of others.
When I think about John's career, I am struck by its breadth. He was a Navy veteran, transplant surgeon, endourologic innovator, residency program director, educator, mentor, and institutional leader. But there is also a remarkable consistency throughout that career. Whether introducing a new way to treat kidney stones, training a young urologist, or overseeing graduate medical education for an entire institution, John was always working to make Duke better and to prepare it for the future.
For those of us in Duke Urology, John was part of a remarkable generation of faculty who built the foundation upon which our department stands today. Many of the things we now take for granted—the strength of our endourology program, our commitment to innovation, and our tradition of excellence in resident education—were built through the efforts of individuals like John.
As Chair of Duke Urology, I feel a particular sense of gratitude for that legacy. We are fortunate to inherit what John and his colleagues created, but with that inheritance also comes a responsibility: to continue building upon it for the generations who follow us.
Perhaps that is the most fitting way to remember an academic physician. Our careers are ultimately not defined simply by the patients we treated, the operations we performed, the papers we published, or the titles we held. They are defined by what we leave behind—the programs we built, the people we taught, and the individuals who became better physicians and leaders because we invested in them.
By that measure, John Weinerth's legacy is extraordinary.
On behalf of the entire Duke Urology family, I extend our deepest sympathy to John's family and to the many friends, colleagues, trainees, and patients whose lives he touched.
We mourn his passing, but we also celebrate a life of tremendous purpose and service. We remember a physician who helped transform the treatment of kidney stone disease at Duke, an educator who helped shape generations of physicians, and a leader whose influence ultimately reached throughout our institution.
We are grateful for John—for what he built, for what he taught us, and for the example he set.
He will be deeply missed, but his legacy will remain an enduring part of the history, the traditions, and the family of Duke Urology.